Nobuaki Matsubara

LATITUDE study: PSA response characteristics and correlation with overall survival (OS) and radiological progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving ADT+abiraterone acetate and prednisone (AAP) or placebo (PBO).

B. Alekseev, K. Chi, N. Tran, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.